Pros
Well funded, some high caliber team members, biopharma connectionsCons
In over their heads and unlikely to realize the full vision on the time table expected by their board - which makes continued funding seem tenuous at best. Success is dependent on adoption by regulatory agencies (re: “governments”) …who will move at their own pace and have conflicting visions for modernization.